Valeant Again Boosts Skin Care Biz With $500M PreCision Buy
Valeant Pharmaceutical International Inc., one of the most acquisitive life sciences companies in recent years, said Monday it will pay up to $500 million to fold PreCision Dermatology Inc. into its...To view the full article, register now.
Already a subscriber? Click here to view full article